People who have recovered from proven coronavirus may be able to help severely ill COVID-19 patients.
UPMC is helping lead a clinical trial in western Pennsylvania that would use plasma from donors who have recovered from COVID-19 to treat people suffering from the disease.
The treatment is called convalescent plasma therapy. The clinical trial, started by clinical researchers at UPMC, is called the COVID Convalescent Plasma Pittsburgh Project (c2p3).
UPMC is seeking people who tested positive for COVID-19 by the nasal swab test and have since recovered to be potential donors for the clinical trial.
Never Miss a Beat!
Subscribe for Updates and Information from UPMC
Sign up for COVID-19 Alerts from UPMC
What Is Convalescent Plasma Therapy?
In convalescent plasma therapy, plasma from people who have recovered from an infection is used to treat people currently infected. The donors’ plasma contains antibodies that potentially can help the recipients fight off the infection.
The use of convalescent plasma therapy dates back more than 100 years. It was used during the measles outbreak in the 1890s and Spanish flu pandemic in the early 20th century.
More recently, convalescent therapy was used for patients during the H1N1 flu outbreak of 2009-10 and to treat patients with Severe Acute Respiratory Syndrome (SARS). SARS is a coronavirus very similar to the COVID-19 virus. These more recent experiences with convalescent plasma therapy were encouraging, suggesting a decrease in severe respiratory symptoms and improved prognosis in hospitalized patients.
Based on the history of using convalescent plasma in these previous viral outbreaks, UPMC clinical researchers have joined with colleagues across the country to assess convalescent plasma in the COVID-19 pandemic and investigate how it can help with treatment.
UPMC is looking for people who were confirmed by nasal swab testing to have COVID-19 and have since recovered to donate plasma for a clinical trial of convalescent plasma therapy.
You might also like…
Can I Donate Plasma for COVID-19 Treatment?
- Potential plasma donors for COVID-19 treatment are people who have tested positive for the coronavirus by the nasal swab test, have fully recovered, and have been symptom-free for at least 21 days.
- The medical team conducting the trial will conduct a phone screening with each potential donor.
- Candidates who pass the screening then will go to UPMC’s Infectious Disease Clinic in the Oakland neighborhood of Pittsburgh. They will be tested for the coronavirus to ensure their infection is gone, and their blood will be tested for antibodies.
- Candidates who have cleared the virus and have COVID-19 antibodies will then be referred to Vitalant blood bank for their plasma donation.
If you have recovered from confirmed COVID-19, are feeling healthy, and are willing to donate your blood, you may be able to help sick patients. Please email firstname.lastname@example.org or call (412) 647-9779 to begin the screening process.
Based in Pittsburgh, UPMC is a world-renowned health care provider and insurer. We operate 40 hospitals and more than 700 doctor’s offices and outpatient centers. Our expert physicians are among the leaders in their fields, and we are leaders in groundbreaking research and treatment breakthroughs. UPMC Presbyterian Shadyside ranks as “One of America’s Best Hospitals” and No. 1 in Pennsylvania in U.S. News & World Report’s listings.